JOMPAC
Journal of Medicine and Palliative Care

Journal of Medicine and Palliative Care (JOMPAC) is an open access scientific journal with independent, unbiased, and double-blind review under international guidelines. The purpose of JOMPAC is to contribute to the literature by publishing articles on health sciences and medicine.

eISSN: 2717-7505
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Submit Manuscript

Index
Original Article
Neutrophil-to-lymphocyte ratio as a predictor of progression in patients with early-stage cervical cancer
Abstract
Aims: The neutrophil-to-lymphocyte ratio (NLR) has shown promise as a prognostic marker in various cancers, but its role in early-stage cervical cancer is not well defined. This study evaluates the association between pre-treatment NLR and progression risk in patients with early-stage cervical cancer.
Methods: This retrospective study included 220 patients with stage I and II cervical cancer treated from 2010 to 2024. Patients with prior treatment, infection at diagnosis, or hematological diseases were excluded. Pre-treatment NLR was calculated from blood counts taken within a week before treatment. Primary outcome was progression-free survival (PFS). Cox regression analyses identified prognostic factors.
Results: The median follow-up was 46 months (range, 1-120). Disease progression occurred in 17.3% of patients, and 15% died. The 5-year overall survival and PFS rates were 84.8% (95% CI: 79.3-90.3) and 77.7% (95% CI: 71.4-84), respectively. Univariate analysis identified non-squamous cell carcinoma (non-SCC) histology, tumor size >4 cm, and elevated NLR as significant factors affecting PFS. Multivariate analysis confirmed non-SCC histology (HR: 3.2, p=0.002), tumor size >4 cm (HR: 2.3, p=0.007), and elevated NLR (HR: 1.1, p=0.041) as independent PFS risk factors. Higher NLR correlated with larger tumor size.
Conclusion: Elevated pre-treatment NLR independently predicts disease progression in early-stage cervical cancer. Incorporating NLR into risk stratification could enhance prognostic assessments and guide personalized treatments. Larger prospective studies are needed for validation.

Keywords : Neutrophil-to-lymphocyte ratio, cervical cancer, progression-free survival.

Download Article


1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. <em>CA Cancer J Clin</em>. 2021;71(3):209-249.
2. Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. <em>CA Cancer J Clin.</em> 2024;74(1):12-49.
3. Hsieh HY, Lu CH, Wang L. Long-term treatment outcomes/toxicities of definite chemoradiotherapy (intensity-modulated radiation therapy) for early-stage &ldquo;bulky&rdquo; cervical cancer and survival impact of histological subtype. <em>J Formos Med Assoc.</em> 2023;122(3):221-229.
4. Dasari S, Wudayagiri R, Valluru L. Cervical cancer: biomarkers for diagnosis and treatment. <em>Clin Chim Acta.</em> 2015;445(12):7-11.
5. Yadav G, Srinivasan G, Jain A. Cervical cancer: novel treatment strategies offer renewed optimism. <em>Pathol Res Pract.</em> 2024;254 (15):155136.
6. Denk D, Greten FR. Inflammation: the incubator of the tumor microenvironment. <em>Trends Cancer</em>. 2022;8(11):901-914.
7. Davidson B, Goldberg I, Kopolovic J. Inflammatory response in cervical intraepithelial neoplasia and squamous cell carcinoma of the uterine cervix. <em>Pathol Res Pract</em>. 1997;193(7):491-495.
8. Templeton AJ, McNamara MG, Seruga B, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. <em>J Natl Cancer Inst.</em> 2014;106(6):124.
9. Zahorec R. Neutrophil-to-lymphocyte ratio, past, present and future perspectives. <em>Bratisl Lek Listy.</em> 2021;122(7):474-488.
10. Cupp MA, Cariolou M, Tzoulaki I, et al. Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies. <em>BMC Med.</em> 2020;18(1):360.
11. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. <em>Cell.</em> 2010;140(6):883-899.
12. Bonavita E, Galdiero MR, Jaillon S, Mantovani A. Phagocytes as corrupted policemen in cancer-related inflammation. <em>Adv Cancer Res.</em> 2015;128(1):141-171.
13. Xiong S, Dong L, Cheng L. Neutrophils in cancer carcinogenesis and metastasis. <em>J Hematol Oncol.</em> 2021;14(1):173.
14. Ardi VC, Kupriyanova TA, Deryugina EI, Quigley JP. Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis. <em>Proc Natl Acad Sci USA.</em> 2007;104(51):20262-20267.
15. Ethier JL, Desautels DN, Templeton AJ, et al. Is the neutrophil-to-lymphocyte ratio prognostic of survival outcomes in gynecologic cancers? A systematic review and meta-analysis. <em>Gynecol Oncol.</em> 2017;145(3):584-594.
16. Zou P, Yang E, Li Z. Neutrophil-to-lymphocyte ratio is an independent predictor for survival outcomes in cervical cancer: a systematic review and meta-analysis. <em>Sci Rep.</em> 2020;10(1):21917.
17. Trinh H, Dzul SP, Hyder J, et al. Prognostic value of changes in neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and lymphocyte-to-monocyte ratio (LMR) for patients with cervical cancer undergoing definitive chemoradiotherapy (dCRT). <em>Clin Chim Acta. </em>2020;510(1):711-716.
18. Du JQ, Zhang F, Wang CQ, et al. Effects of peripheral blood neutrophil/lymphocyte ratio levels and their changes on the prognosis of patients with early cervical cancer. <em>Front Oncol. </em>2023;13(1):1139809.
19. Prabawa IPY, Bhargah A, Liwang F, et al. Pretreatment neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as a predictive value of hematological markers in cervical cancer. <em>Asian Pac J Cancer Prev.</em> 2019;20(3):863-868.
Article available in :
Volume 5, Issue 4, 2024
Page : 203-207
https://doi.org/10.47582/jompac.1495944
Article Information
Received : 04 Haz 2024
Accepted : 18 Ağu 2024
Published : 29 Ağu 2024
Corresponding Author :

Rashad Ismayilov: Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkiye

[email protected]
Citation : Akyıldız A, Ismayilov R, Arık Z. Neutrophil-to-lymphocyte ratio as a predictor of progression in patients with early-stage cervical cancer. J Med Palliat Care. 2024;5(4):203-207.

Read: 206
Cited: 0
Download : 53
_Footer